Monograph No. 044 / Herbals & Others
Herbals & Others
Saw Palmetto: Benefits, Dosage, and Safety
Saw palmetto is a berry extract from the Serenoa repens palm marketed for urinary symptoms of an enlarged prostate, but high-quality NIH-funded trials and a 2023 Cochrane review show it provides little or no benefit.
Saw palmetto is a berry extract from the Serenoa repens palm marketed for urinary symptoms of an enlarged prostate, but high-quality NIH-funded trials and a 2023 Cochrane review show it provides little or no benefit.
What saw palmetto is
Saw palmetto (Serenoa repens) is a small palm native to the southeastern United States and West Indies whose ripe berries are used to make dietary supplements. The extract, standardized to fatty acids and sterols, is sold as capsules, softgels, tablets, and liquid, and is also known by the botanical synonym Sabal serrulata.
What it does
- Marketed (not proven) for urinary symptoms associated with benign prostatic hyperplasia (BPH), an enlarged prostate
- Promoted as a dietary supplement for male-pattern hair loss and chronic prostatitis/chronic pelvic pain syndrome
- Berry fatty-acid and sterol extract proposed to influence androgen-related pathways, though clinical benefit is not established
Intake and dosing
Saw Palmetto is not an essential nutrient, so no Recommended Dietary Allowance or Tolerable Upper Intake Level has been set. Doses in studies vary widely. Because supplement doses are not standardised, discuss an appropriate amount with a clinician or pharmacist.
Deficiency and who is at risk
Not applicable. Saw palmetto is a botanical supplement, not an essential nutrient, so there is no deficiency state or requirement.
Groups more likely to fall short
- Not applicable - no essential biological requirement exists for saw palmetto
Who may need more
- No one requires saw palmetto; it is not an essential nutrient
- Men sometimes try it for BPH urinary symptoms, though NIH-funded trials show it is probably not helpful
- Anyone considering it should first discuss BPH symptoms with a clinician, since symptoms can overlap with more serious prostate conditions
Food sources
Not a dietary nutrient. The source is the berry (fruit) of the Serenoa repens palm; there are no conventional food sources providing a meaningful intake.
Forms and absorption
Sold as capsules, softgels, tablets, liquid extracts, and dried berry preparations. Extracts are classified by extraction method: hexane (for example the commercial Permixon), ethanolic, and supercritical carbon dioxide. Hexane extracts have been proposed to have higher biological activity and lower batch-to-batch variability, but the 2023 Cochrane review found no difference between hexane and other products on BPH symptoms. Product content is not standardized across brands, and supplements are not FDA-approved for potency or purity.
Safety, excess and interactions
NCCIH reports saw palmetto is generally well tolerated, with mild and infrequent adverse effects such as digestive upset, dizziness, and headache; it has been used safely in studies for up to 3 years. It may be unsafe during pregnancy or breastfeeding, and little is known about its safety in women or children. Because it does not appear to change PSA levels, users should be aware it will not mask that screening marker, but self-treating urinary or prostate symptoms may delay diagnosis of serious conditions. Discuss use with a healthcare provider, especially before surgery or if taking anticoagulant or hormone-related medications.
Too much
Saw palmetto is well tolerated and has been used safely in research studies for up to 3 years. Reported adverse effects are mild and infrequent and may include digestive symptoms (such as stomach discomfort), dizziness, and headache. It does not appear to affect prostate-specific antigen (PSA) readings even at higher-than-usual amounts. There is no established toxic threshold, and information on effects at high intakes is limited.
Interactions to know
- NCCIH states saw palmetto has not been shown to interact with medications
- It does not appear to affect prostate-specific antigen (PSA) test readings, even at higher-than-usual amounts, so it should not distort that lab value
- Because saw palmetto is theorized to affect androgen pathways, caution is reasonable with 5-alpha-reductase inhibitors or other hormone-related drugs, though no clinically confirmed interaction is documented by NIH
- Data are limited; as with any supplement, tell your clinician and pharmacist about use, particularly around bleeding risk or surgery
How status is measured
Not routinely measured. There is no clinical lab test for saw palmetto status because it is not an essential nutrient. Prostate symptoms are assessed separately (for example the International Prostate Symptom Score and, where clinically indicated, PSA testing).
What the evidence supports
We grade the strength of evidence behind each common reason people take saw palmetto, mirroring how the NIH describes it.
Strong evidence of NO meaningful benefit. A 2023 Cochrane review of 27 studies (about 4,656 men) and two NIH-funded randomized trials, including doses up to three times the standard 320 mg/day, found little to no difference from placebo in symptoms or quality of life (high-certainty evidence).
Evidence indicates it does NOT appear to affect PSA readings even at higher-than-usual amounts (per NCCIH and the CAMUS trial analysis).
Some single trials suggest combination therapy may help, but the 2023 Cochrane review could not reach definite conclusions about herb combinations; benefit is not established.
A 2022 review of five studies did not find a significant benefit.
Only a few small studies (oral or topical); NCCIH says the evidence is too limited to allow conclusions.
Sources
- S1.gov verifiedNIH National Center for Complementary and Integrative Health (NCCIH)Saw Palmetto: Usefulness and Safetywww.nccih.nih.gov/health/saw-palmetto
- S2.gov verifiedNIH National Center for Complementary and Integrative Health (NCCIH)Spotlight on Saw Palmetto: What the Science Says (NCCIH Clinical Digest, for health professionals)www.nccih.nih.gov/health/providers/digest/spotlight-
- S3.gov verifiedCochrane Database of Systematic ReviewsFranco JV, et al. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement. 2023;6(6):CD001423pmc.ncbi.nlm.nih.gov/articles/PMC10286776/
- S4.gov verifiedNIH Office of Dietary Supplements (ODS)Note: ODS publishes no Saw Palmetto fact sheet and no Dietary Reference Intake (DRI) exists for this botanical; ODS refers to NCCIH for herbal supplement informationods.od.nih.gov/factsheets/list-all/
Every figure on this page is quoted from the sources above. Science changes; we re-check and re-date pages as authorities update their guidance.